AZN Related Mergers and Acquisitions
-
Optimer Pharmaceuticals (OPTR) Jumps as AstraZeneca (AZN), Cubist (CBST) Submit First Round Bids
-
Pfizer (PFE) Gains OTC Rights for NEXIUM; Will Pay Astra (AZN) $250M Upfront
-
Bristol-Myers (BMY), AstraZeneca (AZN) Make Initial $3.2B Payment to Amylin Pharma; AstraZeneca Exercises Rights Option
-
AstraZeneca (AZN) Acquires Neuroscience Assets from Mazzachusetts-Based Link Medicine
-
Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag
-
Amylin (AMLN) Bidding Intensifies; Sale Expected in July
-
Amylin (AMLN) Attracting a Host of Other Suitors, Shares Rise
-
UPDATE - Canaccord Genuity Downgraded Ardea Biosciences (RDEA) To 'Hold'; Q1 Is Non-Event In Light Of Acquisition By AZN
-
Amarin (AMRN) Shares Rise Following M&A Chatter; Other Targets Mentioned (AMLN) (FRX)
-
Brean Murray Carret & Co. Downgrades Ardea Biosciences (RDEA) to Hold; AstraZeneca (AZN) Steps In
-
Amylin (AMLN) Shares Pop on New M&A Chatter (BMY) (AZN)
-
AstraZeneca (AZN) to Acquire Ardea (RDEA) in $1.26B Deal
-
Analysts Expecting Higher Bids for Amylin (AMLN)
-
DENTSPLY (XRAY) Completes Acquisition of Astra Tech from AstraZeneca (AZN)
-
DENTSPLY (XRAY) to Acquire AstraZeneca's (AZN) Astra Tech for $1.8B in Cash
-
AstraZeneca (AZN) Considers Multi-Billion Unit Sale to Dentsply (XRAY)
-
Eli Lilly (LLY) Might Be M&A Target if Things Don't Shape Up
-
AstraZeneca (AZN) Acquire Merck's (MRK) Interest in non-PPI Products
-
Biogen (BIIB) Continues Higher As Icahn Looks to Boost Stake
-
AstraZeneca PLC (AZN) Acquires MedImmune (MEDI) for $58/Share
-
Dow Jones Reports a UK Newspaper says AstraZeneca (AZN) May Look to Acquire Shire (SHPGY)
-
AstraZeneca (AZN) Acquires Cambridge Antibody (CATG)
-
AZN Buys KuDOS Pharmaceuticals for $210M
Back to AZN Stock Lookup
